New and Future Developments in Microbial Biotechnology and Bioengineering: Microbial Biofilms 2020
DOI: 10.1016/b978-0-444-64279-0.00001-3
|View full text |Cite
|
Sign up to set email alerts
|

Microbial biofilms and human disease: A concise review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(20 citation statements)
references
References 116 publications
0
18
0
Order By: Relevance
“…The complex array of chemically and functionally diverse biomolecules in the Eps has been termed the matrixome [ 6 ], which contributes to the peculiar characteristics of biofilm behavior. According to the National Institutes of Health (NIH), bacterial biofilms are responsible for up to 75% of infectious diseases in humans, as implant-related infections and/or tissue-associated infections [ 7 ]. In the European Union and European Economic Area, 8.9 million healthcare-associated infection episodes per year are due to biofilms [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…The complex array of chemically and functionally diverse biomolecules in the Eps has been termed the matrixome [ 6 ], which contributes to the peculiar characteristics of biofilm behavior. According to the National Institutes of Health (NIH), bacterial biofilms are responsible for up to 75% of infectious diseases in humans, as implant-related infections and/or tissue-associated infections [ 7 ]. In the European Union and European Economic Area, 8.9 million healthcare-associated infection episodes per year are due to biofilms [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Staphylococcus aureus is the causative agent of a wide variety of infections in humans and other mammals, owing mainly to the variability of the many virulence factors that it possesses. In particular, this pathogen has the ability to adopt the biofilm lifestyle on tissues and medical device surfaces this conferring several advantages such as evasion of host immunity, which may lead to infection chronicity 1 . Biofilm formation during chronicity is one of the staphylococcal strategies that contributes to the failure of antibacterial therapy 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Biofilm is a community of microbes embedded in a self‐secreted matrix of extracellular polymeric substances (EPS). Biofilms contribute to a significant number of cases (>65%) in healthcare‐associated infections (Yadav et al, 2020) and are also a leading contributor to foodborne disease outbreaks (Srey et al, 2013). These biofilms are resistant to removal or disinfection due to the protective effect of their EPS matrix, a slow growth rate of bacteria in biofilms, and the presence of persister cells (Hall‐Stoodley et al, 2004; Høiby et al, 2010; Yadav et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Biofilms contribute to a significant number of cases (>65%) in healthcare‐associated infections (Yadav et al, 2020) and are also a leading contributor to foodborne disease outbreaks (Srey et al, 2013). These biofilms are resistant to removal or disinfection due to the protective effect of their EPS matrix, a slow growth rate of bacteria in biofilms, and the presence of persister cells (Hall‐Stoodley et al, 2004; Høiby et al, 2010; Yadav et al, 2020). The protection by EPS matrix results from the biopolymer composition that neutralizes antimicrobials (Hall‐Stoodley et al, 2004; Kim, 2016; Yadav et al, 2020).…”
Section: Introductionmentioning
confidence: 99%